Disinfectant/antiseptic resistance genes of Staphylococci and serotyping of clinical Staphylococcus aureus isolates
The Journal of Infection in Developing Countries · 28.02.2026 · 20 (02) · 219-228
DOI: 10.3855/jidc.21412 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 28.02.2026. Verfasst von Hamdullah Suphi Bayraktar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hatay Mustafa Kemal University Experimental Researches Application and Research Center, Antakya, Turkey. Hauptthemen laut MEDLINE: Staphylococcal Infections, Staphylococcus aureus, Drug Resistance, Bacterial, Disinfectants. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Staphylococci are commonly isolated from healthcare settings worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) is among the most important causes of nosocomial infections.
Objectives
This study aims to evaluate the resistance of Staphylococci to the most commonly used disinfectants and antiseptics in healthcare settings and the detection of the dominant serotype of Staphylococcus aureus in Hatay province. Methodology: The frequency of disinfectant/antiseptic resistance genes was detected by the polymerase chain reaction (PCR) technique in identified staphylococcal strains, and antibiotic susceptibility of strains was evaluated phenotypically. Staphylococcus aureus strains were classified in terms of clonal and phylogenetic relationships with Pulse Field Electrophoresis and spa sequence typing methods.
Results
The identification rate of coagulase-negative staphylococci was 43.2% and the others (56.8%) were Staphylococcus aureus. Among these isolates, 103 methicillin-resistant S. aureus were identified. It was determined that 81 (78.64%) of these isolates harbored qacA/B and/or smr genes. The dominant spa serotype was found to be t223.
Conclusions
According to spa serotyping results, it was detected the serotype t223 was the dominant clone in our region, unlike the t030 was dominant in Turkey. Since there are many Syrian immigrants living in the Hatay region due to its geographical location, being the dominant clone of a different serotype has an epidemiologically significant importance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hatay Mustafa Kemal University Experimental Researches Application and Research Center, Antakya, Turkey.
- Çukurova University Faculty of Medicine, Department of Microbiology, Adana, Turkey.
- Hatay Mustafa Kemal University Faculty of Medicine, Department of Microbiology, Antakya, Turkey.
- Hakkari University Faculty of Health Science Department of Nutrition and Dietetics, Hakkâri, Turkey.
- Çukurova University Ceyhan Faculty of Veterinary, Department of Microbiology, Adana, Turkey.
- Mersin University Faculty of Science and Letter, Department of Biotechnology, Mersin, Turkey.
Zitieren
APA
Bayraktar, H. S., Köksal, F., Duran, N., Kandemir, T., Baykara, B., Güven Gökmen, T., & Meral Öcal, M. (2026). Disinfectant/antiseptic resistance genes of Staphylococci and serotyping of clinical Staphylococcus aureus isolates. The Journal of Infection in Developing Countries, 20(02), 219-228. https://doi.org/10.3855/jidc.21412
Vancouver
Bayraktar HS, Köksal F, Duran N, Kandemir T, Baykara B, Güven Gökmen T, et al. Disinfectant/antiseptic resistance genes of Staphylococci and serotyping of clinical Staphylococcus aureus isolates. The Journal of Infection in Developing Countries. 2026;20(02):219-228. doi:10.3855/jidc.21412
BibTeX
@article{Bayraktar2026,
author = {Bayraktar, Hamdullah Suphi and Köksal, Fatih and Duran, Nizami and Kandemir, Tülay and Baykara, Başak and Güven Gökmen, Tülin and Meral Öcal, Melda},
title = {Disinfectant/antiseptic resistance genes of Staphylococci and serotyping of clinical Staphylococcus aureus isolates},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {02},
pages = {219--228},
doi = {10.3855/jidc.21412}
}
EUVIMED